HUSSMAN STRATEGIC ADVISORS, INC.
Position in AMPH — Amphastar Pharmaceuticals, Inc.
CIK 1179475
ELLICOTT CITY, MD
Position in AMPH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,234,170
+$320,985 QoQ
Shares Held
63,000
+100.0% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $14,844,480 across 6 Drug Manufacturers - Specialty & Generic names. AMPH ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
52,500 | $4,037,250 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
105,000 | $3,472,350 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
21,000 | $2,766,540 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
42,000 | $2,323,020 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
This page
|
63,000 | $1,234,170 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
21,000 | $1,011,150 |
All Filings in AMPH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,234,170 | 63,000 | Shares | Sole | 2026-05-11 | |
| 2025-03-31 | $913,185 | 31,500 | Shares | Sole | 2025-05-05 | |
| 2024-06-30 | $2,520,000 | 63,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,766,330 | 63,000 | Shares | Sole | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||